Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (252) clinical trials

The primary objective of this study is to determine whether treatment with an oral investigational drug can slow cognitive decline compared with placebo treatment in individuals who are asymptomatic but at high risk for Alzheimer's disease. Asymptomatic means that the individual is not currently experiencing any symptoms of memory loss ...

Phase

Study Description: CREAD2 is a Phase 3 study investigating the effect of an investigational drug in the form of an infusion on Alzheimer's disease progression in individuals with prodromal to mild Alzheimer's disease. The study drug, crenezumab, is a monoclonal antibody that targets amyloid-beta proteins in the brain. The study ...

Phase

The purpose of this study is to find out if a study drug is safe and effective in the treatment of agitation caused by dementia. Volunteers will receive compensations up to $80.00 per completed visit, for their overall participation in this study to cover their time and travel. Volunteers will ...

The MISSION-AD study is investigating the efficacy and safety of an investigational drug on symptoms of cognitive decline in individuals with mild cognitive impairment or early Alzheimer's disease. The study drug is a tablet which is taken by mouth once per day. The study will last approximately two years. Eligibility ...

Phase N/A

This is a study for elderly patients (>= 55 years of age) who meet the NINCDS-ADRDA criteria for Alzheimer's Disease. Patients screened at visit 1 who will meet all of the inclusion criteria, will be enrolled in the study and receive study therapy. Qualified volunteers will receive compensation up to ...

Phase N/A

Dr. Brian Goldman at Raleigh Medical Group is conducting a clinical research study for probable Alzheimer’s Disease patients of 50 years and older. Qualified participants will receive at no charge, study related physical exams, EKGs, lab work and study medication. They may be compensated for their time and travel. For ...

Phase N/A

This study is for participants that have been diagnosed with a mild to moderate form of Alzheimer's disease (AD). This research involves an experimental study drug known as LY2062430. The primary objective of this study is to test whether LY2062430 will slow the rate of mental (thinking and remembering) decline ...

Phase

Purpose of the study: This research seeks to understand how Down syndrome and Alzheimer’s disease may affect a person’s memory and thinking as they get older. The goals of this longitudinal project are: to follow neurological, learning and memory changes in adults with Down syndrome as they age; to examine ...

Phase N/A

Purpose of the study: This research seeks to understand how Down syndrome and Alzheimer's disease may affect a person's memory and thinking as they get older. The goals of this longitudinal project are: To follow neurological, learning and memory changes in adults with Down syndrome as they age; To examine ...

Phase N/A

NeuroTrials Research is conducting a 20-month, placebo-controlled research study evaluating an investigational drug for Alzheimer’s Disease. Study-related exams and study drug are provided at no cost. Qualified participants and caregivers will be compensated for time and travel. Patient Inclusion Criteria: Age 50-89 Diagnosis of probable Alzheimer’s Disease Must have a ...

Phase